The MidMichigan Health System CME Program must ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. Therefore, all participating activity organizers, program directors, committee members, and lecturers in a sponsored event are expected to disclose any relevant financial relationships. The intent of this disclosure is not to prevent a speaker, presenter, event organizer or committee member who may have influence over material from contributing, but rather to provide activity organizers and listeners with information on which they can make their own judgments. It remains for the audience to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusion.
Although organizers and committee members may not actually present at a planned event, their responsibility of program planning, oversight and credit approval places them in positions to potentially influence educational events. The significance to influence, therefore requires full disclose of potential conflicts of interests in the fulfillment of their responsibilities.
Please disclose all financial relationships that you’ve had in the past 24 months with ineligible companies (see definition below). For each financial relationship, enter the name of the ineligible company and nature of the financial relationship(s). There is no minimum financial threshold; please disclose all financial relationships, regardless of the amount, with ineligible companies. Please disclose all financial relationships regardless of the potential relevance of each relationship to the education.
An ineligible company is any entity whose primary business is producing, marketing, selling, re‐selling, or distributing healthcare products used by or on patients.
Examples of financial relationships include: employee, researcher, consultant, advisor, speaker, independent contractor (including contracted research), royalties, or patent beneficiary, executive role, and ownership interest. Individual stocks and stock options should be disclosed; diversified mutual funds do not need to be disclosed. Research funding from ineligible companies should be disclosed by the principal or named investigator even if that individual’s institution receives the research grants and manages the funds.